Immuno-radiotherapy with cetuximab and avelumab for advanced stage head and neck squamous cell carcinoma: Results from a phase-I trial-Reference-Cited by-同舟云学术

Immuno-radiotherapy with cetuximab and avelumab for advanced stage head and neck squamous cell carcinoma: Results from a phase-I trial

Published:2020-01 Issue: Volume:142 Page:79-84
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Elbers Joris B.W.^ORCID,Al-Mamgani Abrahim^ORCID,Tesseslaar Margot E.T.,van den Brekel Michiel W.M.,Lange Charlotte A.H.,van der Wal Jacqueline E.,Verheij Marcel,Zuur Charlotte L.,de Boer Jan Paul

Funder

Merck B.V

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology,Hematology

Reference38 articles.

1. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted Life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study;Global Burden of Disease Cancer C;JAMA Oncol,2017

2. Concomitant chemoradiotherapy versus acceleration of radiotherapy with or without concomitant chemotherapy in locally advanced head and neck carcinoma (GORTEC 99–02): an open-label phase 3 randomised trial;Bourhis;Lancet Oncol,2012

3. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer;Forastiere;New Engl J Med,2003

4. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck;Bonner;New Engl J Med,2006

5. Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial;Gillison;Lancet,2019

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. FGD-PET/CT three months after (chemo)radiotherapy for head and neck squamous cell carcinoma spares considerable number of patients from a salvage neck dissection;Radiotherapy and Oncology;2024-09

2. The future of cancer treatment: combining radiotherapy with immunotherapy;Frontiers in Molecular Biosciences;2024-07-09

3. Efficacy of nimotuzumab in combination with immunotherapy for a young recurrent cervical cancer patient: a case report and literature review;Anti-Cancer Drugs;2024-05-20

4. Molecular basis, potential biomarkers, and future prospects of OSCC and PD-1/PD-L1 related immunotherapy methods;Heliyon;2024-02

5. A systematic literature review of the human papillomavirus prevalence in locally and regionally advanced and recurrent/metastatic head and neck cancers through the last decade: The “ALARM” study;Cancer Medicine;2024-01-21